Sydney Ch'ng1,2,3, Roman J Skoracki1, Jesse C Selber1, Peirong Yu1, Jack W Martin4, Theresa M Hofstede4, Mark S Chambers4, Jun Liu1, Matthew M Hanasono1. 1. Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. 2. Department of Plastic Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. 3. The Institute of Academic Surgery, University of Sydney, New South Wales, Australia. 4. Dental Oncology Section, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Abstract
BACKGROUND: Dental restoration is an integral part of head and neck cancer reconstruction. METHODS: We evaluated the success rate of osseointegrated implants in patients with head and neck cancer, comparing outcomes between implants placed in fibula free flaps to those placed in native mandibular and maxillary bone. RESULTS: A total of 1132 implants were placed in 246 patients. The overall implant loss rate was 3.7% and was higher in fibula flaps (8.2%) compared to the native mandible (2.6%) and maxilla (2.2%), although these differences did not reach statistical significance (p = .059 and p = .053, respectively). The failure rate was 8.0% for implants placed after radiation and 3.6% in patients who did not undergo radiation (p = .097). Osteoradionecrosis (ORN) occurred in 19 patients (7.7%) after implant placement, and tobacco use was found to be a risk factor (p = .027). CONCLUSION: Osseointegrated implants are reliable in patients with head and neck cancer, including those undergoing bony free flap reconstruction.
BACKGROUND: Dental restoration is an integral part of head and neck cancer reconstruction. METHODS: We evaluated the success rate of osseointegrated implants in patients with head and neck cancer, comparing outcomes between implants placed in fibula free flaps to those placed in native mandibular and maxillary bone. RESULTS: A total of 1132 implants were placed in 246 patients. The overall implant loss rate was 3.7% and was higher in fibula flaps (8.2%) compared to the native mandible (2.6%) and maxilla (2.2%), although these differences did not reach statistical significance (p = .059 and p = .053, respectively). The failure rate was 8.0% for implants placed after radiation and 3.6% in patients who did not undergo radiation (p = .097). Osteoradionecrosis (ORN) occurred in 19 patients (7.7%) after implant placement, and tobacco use was found to be a risk factor (p = .027). CONCLUSION: Osseointegrated implants are reliable in patients with head and neck cancer, including those undergoing bony free flap reconstruction.
Authors: Sagar Kansara; Tao Wang; Sina Koochakzadeh; Nelson E Liou; Evan M Graboyes; Judith M Skoner; Joshua D Hornig; Vlad C Sandulache; Terry A Day; Andrew T Huang Journal: Oral Oncol Date: 2019-09-12 Impact factor: 5.337
Authors: Robert J Allen; Jonas A Nelson; Thais O Polanco; Meghana G Shamsunder; Ian Ganly; Jay Boyle; Evan Rosen; Evan Matros Journal: Plast Reconstr Surg Date: 2020-12 Impact factor: 5.169
Authors: Robert J Allen; Deana S Shenaq; Evan B Rosen; Snehal G Patel; Ian Ganly; Jay O Boyle; Jonas A Nelson; Evan Matros Journal: Plast Reconstr Surg Glob Open Date: 2019-01-14
Authors: Rachel A Anolik; Jonas A Nelson; Evan B Rosen; Joseph Disa; Evan Matros; Robert J Allen Journal: Plast Reconstr Surg Glob Open Date: 2021-09-17
Authors: Gustaaf J C van Baar; Kitty Schipper; Tymour Forouzanfar; Lars Leeuwrik; Henri A H Winters; Angela Ridwan-Pramana; Frank K J Leusink Journal: J Clin Med Date: 2021-03-16 Impact factor: 4.241